Biotech · Private company
Taiwan Liposome Company
Track this companyFree. Adds Taiwan Liposome Company to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- DSPPhase 3 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- TLC599Phase 3 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- BupivacainePhase 2 · Hallux ValgusClinicalTrials.gov · fetched Nov 12, 2026
- NaropinPhase 2 · Inguinal HerniaClinicalTrials.gov · fetched Nov 12, 2026
- Naropin®Phase 2 · Hallux ValgusClinicalTrials.gov · fetched Nov 12, 2026
- TLC178Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- TLC399 (ProDex)Phase 2 · Retinal Vein OcclusionClinicalTrials.gov · fetched Nov 12, 2026
- TLC590Phase 2 · Hallux ValgusClinicalTrials.gov · fetched Nov 12, 2026
- TLC590Phase 2 · Inguinal HerniaClinicalTrials.gov · fetched Nov 12, 2026
- LipotecanPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA PainPHASE3 · COMPLETED · started Nov 26, 2019ClinicalTrials.gov NCT04123561 · fetched Nov 12, 2026
- A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following BunionectomyPHASE2 · COMPLETED · started Mar 5, 2019ClinicalTrials.gov NCT03838133 · fetched Nov 12, 2026
- A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the KneePHASE2 · COMPLETED · started Jan 21, 2019ClinicalTrials.gov NCT03754049 · fetched Nov 12, 2026
- Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain ManagementPHASE1_PHASE2 · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03591146 · fetched Nov 12, 2026
- Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced MalignancyPHASE1_PHASE2 · COMPLETED · started Jun 19, 2017ClinicalTrials.gov NCT02925000 · fetched Nov 12, 2026
- TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)PHASE2 · COMPLETED · started Apr 1, 2017ClinicalTrials.gov NCT03093701 · fetched Nov 12, 2026
- Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 1, 2008ClinicalTrials.gov NCT00747474 · fetched Nov 12, 2026